# EDGAR Filing Document

**Accession Number:** 0001839533
**File Stem:** 0000094049-26-000022
**Filing Date:** 2026-2
**Character Count:** 9534
**Document Hash:** 41ff4100ec4af4c396400cf9d9b6580e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000094049-26-000022.hdr.sgml**: 20260219

**ACCESSION NUMBER**: 0000094049-26-000022

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260217

**FILED AS OF DATE**: 20260219

**DATE AS OF CHANGE**: 20260219

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Stepan Richard Finn
- **CENTRAL INDEX KEY:** 0001839533

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04462
- **FILM NUMBER:** 26656353

**MAIL ADDRESS:**
- **STREET 1:** 22 WEST FRONTAGE ROAD
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STEPAN CO
- **CENTRAL INDEX KEY:** 0000094049
- **STANDARD INDUSTRIAL CLASSIFICATION:** SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 361823834
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** EDENS & WINNETKA ROAD
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093
- **BUSINESS PHONE:** 8474467500

**MAIL ADDRESS:**
- **STREET 1:** EDENS & WINNETKA ROAD
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STEPAN CHEMICAL CO /DE/
- **DATE OF NAME CHANGE:** 19840108

## Ex-24

```

POWER OF ATTORNEY

	KNOW ALL MEN BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints each of Shawn Lisle, Kamel Aranki, James Hart
and Darina Koleva, signing singly, as the undersigned?s
true and lawful authorized representatives and attorneys-in-fact
to:

(1)	execute for and on behalf of the undersigned, in the
undersigned?s capacity as an executive officer of Stepan Company
(?the Company?), Forms 3, 4 and 5, and any and all amendments
thereto, in accordance with Section 16 of the Securities Exchange
Act of 1934, as amended (the ?1934 Act?), and the rules and
regulations promulgated thereunder;

(2)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete the
execution of any such form or schedule and the timely filing of
such form or schedule with the United States Securities and
Exchange Commission and any stock exchange or stock market or
other authority; and

(3)	take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorneys-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by such attorneys-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorneys-in-fact may
approve in such attorneys-in-fact?s discretion.

	The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform all and every act and
thing whatsoever requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully
to all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorneys-in-fact, or
such attorneys-in-fact?s substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.  The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at
the request of the undersigned, are not assuming, nor is the Company
assuming any of the undersigned?s responsibilities to comply with
Section 16 or any other provision of the 1934 Act.

	This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned?s holdings of and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-
in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 12th Day of January 2026.

/s/ Richard F. Stepan
Richard F. Stepan

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Stepan Richard Finn<br><sub>(Last) (First) (Middle)</sub><br>1101 SKOKIE BOULEVARD, SUITE 500<br><sub>(Street)</sub><br>NORTHBROOK, IL 60062<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_V.P. and Gen'l. Mgr., Polymers_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>STEPAN CO [ SCL ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-02-17 |  | M<sup>(1)</sup> |  | 341 | A | $66.39 | 241457.15 | D |  |
| Common Stock | 2026-02-17 |  | F<sup>(2)</sup> |  | 118 | D | $66.39 | 241339.15 | D |  |
| Common Stock |  |  |  |  |  |  |  | 43439 | I | By Daughter |
| Common Stock |  |  |  |  |  |  |  | 43439 | I | By Daughter |
| Common Stock |  |  |  |  |  |  |  | 43439 | I | By Son |
| Common Stock |  |  |  |  |  |  |  | 5174 | I | By Spouse |
| Common Stock |  |  |  |  |  |  |  | 95416 | I | By Trust |
| Common Stock |  |  |  |  |  |  |  | 1238.22 | I | By ESOP II Trust |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2026-02-17 |  | M<sup>(1)</sup> |  |  | 341 | 2024-02-14<sup>(4)</sup> | 2026-02-14 | Restricted Stock Units | 341 | $0 | 0 | D |  |

---

### Footnotes:

(1) The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award.

(2) Withholding of shares to satisfy tax liability on the vesting of RSUs.

(3) Each RSU represents a contingent right to receive one share of Stepan Company common stock.

(4) Vests ratably over three years beginning on the date shown.

**Signature:** /s/ James A. Hart, attorney-in-fact for Mr. Richard Stepan  
**Date:** 2026-02-19

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**